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ObituaryMax L. Birnstiel (1933–2014)Max L. BirnstielWhen I first met Max in Zurich in the fall of
1974, ‘‘Switzerland’’ seemed to be written
all over him. I had just arrived from the
United States, and his reserved polite-
ness, his aversion to jokes, and his habit
of neither wasting nor mincing his words
all fitted the cliche´ of the Swiss German.
My impression was reinforced when he
told me that his paternal ancestors had
been gunpowder manufacturers and he
himself had served as an artillery officer
in the Swiss Army. It was only later that I
learned that about half of his genes—
and all of his mitochondrial ones—came
from sea-faring Portuguese who had
settled in Brazil sometime in the past.
The two genomes entered this world
united in Bahia on July 12, 1933when little
Max was born to the Swiss merchant
Max Birnstiel and his Brazilian wife Dalila
Varella. When Max was five, his parents
decided to move to Switzerland in order
to allow Max and his brother Fritz to get
a solid education. Max attended primary
school and gymnasium in Zurich and
then enrolled at the Swiss Federal Insti-
tute of Technology with the goal of study-
ing biology, a subject that had fascinated
him since childhood. On the advice of
the botanist Albert Frey-Wyssling, he
majored in physical chemistry—at that
time an unorthodox gradus ad Parnassum
for an aspiring biologist. As Max tells it,
he never regretted this choice, as it
taught him to look at complex biological
systems with a quantitative eye. After his
doctoral thesis with Frey-Wyssling, he
spent 3 1/2 years at the California Institute
of Technology at Pasadena, working as
a postdoctoral fellow with the botanist
James Bonner. This stay at one of the
world’s premier scientific institutions
brought him face to face with scientific
giants such as Linus Pauling, George
Beadle, Max Delbru¨ck, and Renato
Dulbecco and the first stirrings of the bio-
logical revolution. His postdoctoral work
led to the discovery that the ribosomal
RNA genes of the plant Pisum sativum
were highly repetitive, existing in hun-
dreds of copies. Max was never quite
satisfied with his postdoctoral harvest
even though it furnished the basis of
some of his breakthrough discoveriessoon to come. His collaboration at Cal-
tech with the British biologist Margaret
Chipchase on ribosomal RNA genes was
also fruitful in other ways: the two married
in 1961.
In 1963, Conrad H. Waddington re-
cruited the promising young Swiss to
the Epigenetics Research Group at the
Genetics Department of the University
of Edinburgh, where Max rapidly rose
through the ranks from Lecturer all the
way to Professor. Inspired by his post-
doctoral work on plant ribosomal RNAs,
Max, his PhD students Adrian Bird and
Michael Grunstein, together with team
members started investigating the repeti-
tive ribosomal RNA genes of the South Af-
rican toad Xenopus laevis. By hybridizing
total Xenopus DNA to the two major Xen-
opus ribosomal RNAs and subjecting the
hybrids to isopycnic centrifugation in
cesium chloride gradients, they purified
the reiterated RNA genes as complexes
with their cognate RNAs—the first gene
purification ever, well before the advent
of gene cloning. The ribosomal RNA
genes could also be purified directly by
repeated gradient centrifugation because
they had an unusually high G+C content
and, hence, a higher buoyant density
than the bulk DNA. By today’s standards,Cell 16methods for studying genes were still
paltry, but Max and his team could show
that the genes were located in the nucle-
olus in a head-to-tail tandem arrange-
ment. By 1971, when he was promoted
to professor, Max was already a major
player in the new and competitive field
of molecular biology.
When the University of Zu¨rich offered
him a chair in molecular biology in 1972,
the OPEC oil shock had not yet rocked
the West and Switzerland was still bask-
ing in the glow of financial opulence. The
offer was thus very generous but came
with a hitch: the university had already
given one of the molecular biology chairs
to Charles Weissmann, and it seemed
likely that a shared institute would be too
confining a habitat for two stellar and
strong-willed scientists. The Solomonic
solution was to split the Institute into an
Institute I, headed byCharlesWeissmann,
and an Institute II, headed by Max Birn-
stiel. Max was never quite at ease with
this solution, but his resources at Zurich
and his growing scientific reputation
allowed him to attract an impressive cast
of bright young scientists, including,
among others, Carmen Birchmeier, Mein-
rad Busslinger, Rudolf Grosschedl,Walter
Schaffner, and John L. Telford.
In Zurich, Max applied improved den-
sity gradient procedures to purifying the
repetitive 5S RNA genes of Xenopus
laevis and the five clustered histone genes
of the sea urchin Psammechinus miliaris.
Never before had protein-coding genes
from a multicellular organism been
purified and studied in such detail. But
this tour de force marked the end of an
era. By 1975, gene cloning had entered
the scene, rendering gene purification by
physical methods obsolete.
Although by that time Max had stopped
doing experiments himself, he retained an
amazing experimental intuition. Walter
Schaffner recounts how Max thought
up an ingenious trick of injecting DNA
into oocyte nuclei, which turned out
to be crucial in defining DNA elements
regulating gene transcription and RNA
processing. Another such suggestion led
to an effective method for recovering
intact RNA from Xenopus oocytes. And0, January 15, 2015 ª2015 Elsevier Inc. 11
an impressive string of highly original
studies, done together with his gifted
collaborators, soon threw new light on
the promoters of tRNA genes and the
cis-regulatory sequences and trans-
acting factors governing 30 end process-
ing of mRNAs. Particularly exciting was
the discovery together with Rudolf Gros-
schedl of a ‘‘modulator’’ element more
than 100 nucleotides upstream of the his-
tone H2A gene promoter. This element
acted in an orientation-independent
manner and was thus the first member
of the ‘‘enhancers’’ studied later by
others. In 1986, 14 years after his recruit-
ment to Zu¨rich, the Birnstiel laboratory
went from strength to strength, showing
no sign of slowing down. Always the
good scientific citizen, Birnstiel also
served as Chairman of the EMBO Council
and organized international conferences
on gene regulation that drew large audi-
ences from all over the world. Many
honors began to come his way, including
foreign membership in the US National
Academy of Sciences, honorary doctor-
ates and professorships, the prestigious
Naegeli Prize, and, later, medals of all
stripes and colors. By the mid-1980s,
Max was an admired international figure
and an icon of Swiss science.
Fate had other plans, however. At the
suggestion of the Austrian biochemist
Peter Swetly, the US biotech pioneer
Genentech and the German pharmaceu-
tical giant Boehringer Ingelheim decided
to establish a biomedical research Insti-
tute in Vienna, a city not known as a center
of biomedicine. The crucial point was to
find a high-profile scientist courageous
enough to move to Vienna and set up a
research Institute there. I had just visited
Max in Zu¨rich and sensed his eagerness
for a change. When I asked him whether12 Cell 160, January 15, 2015 ª2015 Elsevierhe would be willing to head a new, pri-
vately funded biomedical research insti-
tute, he was immediately interested. But
when he then asked ‘‘where is that insti-
tute going to be?’’, my reply ‘‘in Vienna’’
seemed to offend him and he said ‘‘no.’’
Early the next morning, however, my
phone rang—it was Max. ‘‘Is the job still
available?’’ he asked. This tongue-in-
cheek question and the enthusiastic
reaction by the two founder companies
opened a new chapter in Max’s life and
in Austrian biomedicine. Max was a
perfect choice for the challenge. He
accepted under the condition that the
molecular biology departments of Vienna
University (now theMax L. Perutz Labora-
tories) would move next to his new ‘‘Insti-
tute of Molecular Pathology’’ (IMP), which
was to be erected at the site of a defunct
manufacturing facility. This visionary de-
mand spawned Austria’s leading life
science campus, which today houses
the IMP, the Max L. Perutz Laboratories,
and several biological research institutes
of the Austrian Academy of Sciences, as
well as biotech spin-offs. In no time, Max
had recruited five first-rate young scien-
tists as group leaders who were to shape
the IMP during its crucial starting phase
and beyond. Adrian Bird came from
the MRC Laboratories in Edinburgh, Kim
Nasmyth from the Laboratory of Molecu-
lar Biology in Cambridge, Hartmut Beug
and Erwin Wagner from the European
Molecular Biology Laboratory (EMBL) in
Heidelberg, and Meinrad Busslinger
accompanied Max from Zurich. By
creating a set of core facilities, Max gave
the young IMP an edge over its competi-
tors and quickly propelled it into the top
league of biomedical research centers.
At the IMP, Max continued his work on
eukaryotic gene regulation but alsoInc.ventured into new areas. He searched
for new cancer vaccines by transfecting
murine cells by means of inactivated
adenovirus particles and transferrin-poly-
cation conjugates in order to generate
cytokine-secreting autologous tumor
cells. At work he was direct, demanding
and imperial as ever, but Vienna also
exposed his Brazilian heritage and the
manifold layers of his complex persona.
He had always appreciated the good
things in life—wines, cigars, haute
cuisine, and classical music—but now
he could officially savor them with his
many visitors. And he seemed to take
mischievous pleasure in standing up to
Austria’s labyrinthine bureaucracy and
mastering its mysterious titles. When he
handed over the IMP directorship to Kim
Nasmyth in 1996, he could look back to
a period of astonishing achievement and
personal happiness. After his return to
Switzerland, he enjoyed traveling with
his wife and children and playing classical
music on his recorder. Early in 2014, he
discovered a growth on his neck, which
was diagnosed as an inoperable cancer.
During the subsequent radiation treat-
ment, his heart failed and he died on
November 15 in a hospital near Wollerau,
the Swiss village he had chosen for the
final years of his eventful and brilliant life.
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